These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29254380)

  • 1. Multiple molecular modelling studies on some derivatives and analogues of glutamic acid as matrix metalloproteinase-2 inhibitors.
    Jha T; Adhikari N; Saha A; Amin SA
    SAR QSAR Environ Res; 2018 Jan; 29(1):43-68. PubMed ID: 29254380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring QSAR and pharmacophore mapping of structurally diverse selective matrix metalloproteinase-2 inhibitors.
    Halder AK; Saha A; Jha T
    J Pharm Pharmacol; 2013 Oct; 65(10):1541-54. PubMed ID: 24028622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insight into the structural requirement of aryl sulphonamide based gelatinases (MMP-2 and MMP-9) inhibitors - Part I: 2D-QSAR, 3D-QSAR topomer CoMFA and Naïve Bayes studies - First report of 3D-QSAR Topomer CoMFA analysis for MMP-9 inhibitors and jointly inhibitors of gelatinases together.
    Das S; Amin SA; Jha T
    SAR QSAR Environ Res; 2021 Aug; 32(8):655-687. PubMed ID: 34355614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydropyrazothiazole derivatives as potential MMP-2/MMP-8 inhibitors for cancer therapy.
    Wang ZC; Shen FQ; Yang MR; You LX; Chen LZ; Zhu HL; Lu YD; Kong FL; Wang MH
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3816-3821. PubMed ID: 30342958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.
    Yan XQ; Wang ZC; Li Z; Wang PF; Qiu HY; Chen LW; Lu XY; Lv PC; Zhu HL
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4664-71. PubMed ID: 26346367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.
    Adhikari N; Halder AK; Mallick S; Saha A; Saha KD; Jha T
    Bioorg Med Chem; 2016 Sep; 24(18):4291-4309. PubMed ID: 27452283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing structural insights into in-house arylsulfonyl L-(+) glutamine MMP-2 inhibitors as promising anticancer agents through structure-based computational modelling approaches.
    Baidya SK; Banerjee S; Ghosh B; Jha T; Adhikari N
    SAR QSAR Environ Res; 2023; 34(10):805-830. PubMed ID: 37850742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined 2D and 3D-QSAR, molecular modelling and docking studies of pyrazolodiazepinones as novel phosphodiesterase 2 inhibitors.
    Bhansali SG; Kulkarni VM
    SAR QSAR Environ Res; 2014; 25(11):905-37. PubMed ID: 25401514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesteryl ester transfer protein inhibitors in coronary heart disease: Validated comparative QSAR modeling of N, N-disubstituted trifluoro-3-amino-2-propanols.
    Mondal C; Halder AK; Adhikari N; Jha T
    Comput Biol Med; 2013 Oct; 43(10):1545-55. PubMed ID: 24034746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural exploration of hydroxyethylamines as HIV-1 protease inhibitors: new features identified.
    Amin SA; Adhikari N; Bhargava S; Jha T; Gayen S
    SAR QSAR Environ Res; 2018 May; 29(5):385-408. PubMed ID: 29566580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QSAR analyses on avian influenza virus neuraminidase inhibitors using CoMFA, CoMSIA, and HQSAR.
    Zheng M; Yu K; Liu H; Luo X; Chen K; Zhu W; Jiang H
    J Comput Aided Mol Des; 2006 Sep; 20(9):549-66. PubMed ID: 17103017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insight into the structural requirements of pyrimidine-based phosphodiesterase 10A (PDE10A) inhibitors by multiple validated 3D QSAR approaches.
    Halder AK; Amin SA; Jha T; Gayen S
    SAR QSAR Environ Res; 2017 Mar; 28(3):253-273. PubMed ID: 28322591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor-based 3D-QSAR approach to find selectivity features of flexible similar binding sites: case study on MMP-12/MMP-13.
    Hadizadeh F; Shamsara J
    Int J Bioinform Res Appl; 2015; 11(4):326-46. PubMed ID: 26561318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D-QSAR analysis of a series of S-DABO derivatives as anti-HIV agents by CoMFA and CoMSIA.
    Xu HR; Fu L; Zhan P; Liu XY
    SAR QSAR Environ Res; 2016 Dec; 27(12):999-1014. PubMed ID: 27667445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QSAR analysis of thiolactone derivatives using HQSAR, CoMFA and CoMSIA.
    Sainy J; Sharma R
    SAR QSAR Environ Res; 2015; 26(10):873-92. PubMed ID: 26524489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New p-methylsulfonamido phenylethylamine analogues as class III antiarrhythmic agents: design, synthesis, biological assay, and 3D-QSAR analysis.
    Liu H; Ji M; Luo X; Shen J; Huang X; Hua W; Jiang H; Chen K
    J Med Chem; 2002 Jul; 45(14):2953-69. PubMed ID: 12086482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Employing comparative QSAR techniques for the recognition of dibenzofuran and dibenzothiophene derivatives toward MMP-12 inhibition.
    Tamang JSD; Banerjee S; Baidya SK; Ghosh B; Adhikari N; Jha T
    J Biomol Struct Dyn; 2024 Sep; 42(14):7304-7320. PubMed ID: 37498149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
    Bhongade BA; Gadad AK
    J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A robust classification-dependent multi-molecular modelling study on some biphenyl sulphonamide based MMP-8 inhibitors.
    Guti S; Baidya SK; Banerjee S; Adhikari N; Jha T
    SAR QSAR Environ Res; 2021 Oct; 32(10):835-861. PubMed ID: 34587852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.
    Matter H; Schwab W; Barbier D; Billen G; Haase B; Neises B; Schudok M; Thorwart W; Schreuder H; Brachvogel V; Lönze P; Weithmann KU
    J Med Chem; 1999 Jun; 42(11):1908-20. PubMed ID: 10354399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.